Global Sotorasib Tablets Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Sotorasib Tablets Global Market Report 2025

Name: Sotorasib Tablets Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Dosage Form (40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms); By Patient Demographics (Adolescents, Adult, Senior Adults); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels); By Application (Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications); By End-User (Hospitals, Oncology Centers, Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Sotorasib Tablets Market Overview

• Sotorasib Tablets market size has reached to $1.71 billion in 2024

• Expected to grow to $3.04 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%

• Growth Driver: Rising Prevalence Of Cancer Fueling The Market Growth Due To Increasing Life Expectancy

• Market Trend: Combination Therapies Show Promise In Extending Progression-Free Survival In Advanced Cancers

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sotorasib Tablets Market?

Sotorasib tablets are a prescription medicine developed for the treatment of certain cases of non-small cell lung cancer in patients whose tumors carry the KRAS G12C gene mutation. The medicine works by binding to the abnormal KRAS protein, preventing it from sending signals that drive the uncontrolled growth and survival of cancer cells. This targeted inhibition can reduce tumor activity, slow disease progression, and improve treatment outcomes in patients who have limited options with standard therapies.

The main dosage forms of sotorasib tablets are 40 milligrams (mg), 120 milligrams (mg), 240 milligrams (mg), and other dosage forms. The 40 mg tablets are a lower-strength form of the KRAS G12C inhibitor Lumakras, enabling precise dose adjustments for improved safety and tolerability. Sotorasib is used in patient populations including adolescents, adults, and senior adults. It is distributed through various channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels, and is used for applications including non-small cell lung cancer, Colorectal Cancer, and other indications. The end-users include hospitals, oncology centers, clinics, and other healthcare providers.

Sotorasib Tablets Market Size and growth rate 2025 to 2029: Graph

What Is The Sotorasib Tablets Market Size 2025 And Growth Rate?

What Is The Sotorasib Tablets Market Growth Forecast?

The sotorasib tablets market size is expected to see rapid growth in the next few years. It will grow to $3.04 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to growing investment in KRAS inhibitor research, expansion of sotorasib manufacturing capacity, increasing collaborations between biotech and pharma companies, rising demand for personalized cancer treatment, and growing use of oral targeted therapies. Major trends in the forecast period include technological advancements in targeted therapy development, developments in KRAS mutation detection methods, investment research and development in oncology drugs, innovation in oral cancer formulations, and advancements in sustainable drug manufacturing practices.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Sotorasib Tablets Market Segmented?

1) By Dosage Form: 40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms

2) By Patient Demographics: Adolescents, Adult, Senior Adults

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By Application: Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications

5) By End-User: Hospitals, Oncology Centers, Clinics, Other End-Users

What Is Driving The Sotorasib Tablets Market? Rising Prevalence Of Cancer Fueling The Market Growth Due To Increasing Life Expectancy

The rising prevalence of cancer is expected to propel the growth of the sotorasib tablets market going forward. Cancer is a group of diseases where abnormal cells grow uncontrollably, invade tissues, and can spread to other parts of the body. The increasing cancer prevalence is due to aging population, as advanced age is the most significant risk factor for developing most types of cancer, with the majority of cases occurring in individuals over 65 years old. Sotorasib tablets work by selectively and irreversibly targeting the KRAS G12C mutation, permanently locking the mutated protein in the off position to prevent uncontrolled cell growth in patients with advanced solid tumors, particularly non-small cell lung cancer. For instance, in February 2024, according to the World Health Organization, a Switzerland-based international organization specializing in global health policy and public health initiatives, over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the sotorasib tablets industry.

Who Are The Major Players In The Global Sotorasib Tablets Market?

Major companies operating in the sotorasib tablets market are Amgen Inc., Ziska Pharmaceuticals Limited, Everest Pharmaceuticals Inc., Lucius Pharmaceutical Co. Ltd.

What Are The Key Trends Of The Global Sotorasib Tablets Market? Combination Therapies Show Promise In Extending Progression-Free Survival In Advanced Cancers

Major companies operating in the sotorasib tablets market are focusing on developing innovative therapies such as combination treatments to improve efficacy and overcome resistance. Combination treatments refer to using two or more drugs together to target cancer through multiple mechanisms simultaneously, helping to increase treatment effectiveness, overcome or delay drug resistance, reduce the likelihood of cancer recurrence, and improve overall patient outcomes and quality of life. For instance, in January 2025, Amgen Inc., a US-based biotechnology company, received U.S. Food and Drug Administration (FDA) approval for sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C–mutated metastatic colorectal cancer (mCRC) who had previously received standard chemotherapy. This approval was based on the results of the Phase 3 CodeBreaK 300 study, which demonstrated that the combination more than doubled progression-free survival compared to the investigator’s choice of standard-of-care therapy, providing a significant new option for patients with this difficult-to-treat cancer. Sotorasib is a first-in-class, oral KRAS G12C inhibitor that works by selectively targeting and locking the mutant KRAS protein in its inactive state, thereby blocking cancer cell growth and signaling pathways driven by this mutation.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Sotorasib Tablets Market? Astrazeneca Plc Acquires Fusion Pharmaceuticals Inc. To Advance Next-Generation Targeted Alpha-Therapy

In October 2022, BridgeBio Pharma, a US-based biopharmaceutical company focused on genetic diseases and cancers, partnered with Amgen to evaluate the combination of BBP-398 and Lumakras in patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC). With this partnership, BridgeBio and Amgen aim to develop and test this combination as a potentially more effective treatment for patients, addressing the serious unmet medical needs associated with KRAS G12C-mutated NSCLC. Amgen is a US-based biopharmaceutical company that specializes in developing innovative therapies for serious illnesses, including sotorasib for KRAS G12C-mutated cancers.

What Is The Regional Outlook For The Global Sotorasib Tablets Market?

North America was the largest region in the sotorasib tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sotorasib Tablets Market?

The sotorasib tablets market consists of sales of lumakras, lumykras, and diagnostic companion kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Sotorasib Tablets Industry?

The sotorasib tablets market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sotorasib tablets industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

1. Executive Summary

2. Sotorasib Tablets Market Characteristics

3. Sotorasib Tablets Market Trends And Strategies

4. Sotorasib Tablets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sotorasib Tablets Growth Analysis And Strategic Analysis Framework

5.1. Global Sotorasib Tablets PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Sotorasib Tablets Market Growth Rate Analysis

5.4. Global Sotorasib Tablets Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Sotorasib Tablets Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Sotorasib Tablets Total Addressable Market (TAM)

6. Sotorasib Tablets Market Segmentation

6.1. Global Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

40 Milligrams (Mg) Tablets

120 Milligrams (Mg) Tablets

240 Milligrams (Mg) Tablets

Other Dosage Forms

6.2. Global Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adolescents

Adult

Senior Adults

6.3. Global Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Other Distribution Channels

6.4. Global Sotorasib Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Small Cell Lung Cancer

Colorectal Cancer

Other Applications

6.5. Global Sotorasib Tablets Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Oncology Centers

Clinics

Other End-Users

7. Sotorasib Tablets Market Regional And Country Analysis

7.1. Global Sotorasib Tablets Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Sotorasib Tablets Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sotorasib Tablets Market

8.1. Asia-Pacific Sotorasib Tablets Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sotorasib Tablets Market

9.1. China Sotorasib Tablets Market Overview

9.2. China Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sotorasib Tablets Market

10.1. India Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sotorasib Tablets Market

11.1. Japan Sotorasib Tablets Market Overview

11.2. Japan Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sotorasib Tablets Market

12.1. Australia Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sotorasib Tablets Market

13.1. Indonesia Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sotorasib Tablets Market

14.1. South Korea Sotorasib Tablets Market Overview

14.2. South Korea Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sotorasib Tablets Market

15.1. Western Europe Sotorasib Tablets Market Overview

15.2. Western Europe Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sotorasib Tablets Market

16.1. UK Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sotorasib Tablets Market

17.1. Germany Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sotorasib Tablets Market

18.1. France Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sotorasib Tablets Market

19.1. Italy Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sotorasib Tablets Market

20.1. Spain Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sotorasib Tablets Market

21.1. Eastern Europe Sotorasib Tablets Market Overview

21.2. Eastern Europe Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sotorasib Tablets Market

22.1. Russia Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sotorasib Tablets Market

23.1. North America Sotorasib Tablets Market Overview

23.2. North America Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sotorasib Tablets Market

24.1. USA Sotorasib Tablets Market Overview

24.2. USA Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sotorasib Tablets Market

25.1. Canada Sotorasib Tablets Market Overview

25.2. Canada Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sotorasib Tablets Market

26.1. South America Sotorasib Tablets Market Overview

26.2. South America Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sotorasib Tablets Market

27.1. Brazil Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sotorasib Tablets Market

28.1. Middle East Sotorasib Tablets Market Overview

28.2. Middle East Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sotorasib Tablets Market

29.1. Africa Sotorasib Tablets Market Overview

29.2. Africa Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sotorasib Tablets Market Competitive Landscape And Company Profiles

30.1. Sotorasib Tablets Market Competitive Landscape

30.2. Sotorasib Tablets Market Company Profiles

30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Ziska Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Everest Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Lucius Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Global Sotorasib Tablets Market Competitive Benchmarking And Dashboard

32. Key Mergers And Acquisitions In The Sotorasib Tablets Market

33. Recent Developments In The Sotorasib Tablets Market

34. Sotorasib Tablets Market High Potential Countries, Segments and Strategies

34.1 Sotorasib Tablets Market In 2029 - Countries Offering Most New Opportunities

34.2 Sotorasib Tablets Market In 2029 - Segments Offering Most New Opportunities

34.3 Sotorasib Tablets Market In 2029 - Growth Strategies

34.3.1 Market Trend Based Strategies

34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations

35.2. Currencies

35.3. Historic And Forecast Inflation Rates

35.4. Research Inquiries

35.5. The Business Research Company

35.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Sotorasib Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Sotorasib Tablets Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Sotorasib Tablets Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Sotorasib Tablets Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Amgen Inc. Financial Performance

Table 77: Ziska Pharmaceuticals Limited Financial Performance

Table 78: Everest Pharmaceuticals Inc. Financial Performance

Table 79: Lucius Pharmaceutical Co. Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Sotorasib Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Sotorasib Tablets Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Sotorasib Tablets Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Sotorasib Tablets Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Amgen Inc. Financial Performance

Figure 77: Ziska Pharmaceuticals Limited Financial Performance

Figure 78: Everest Pharmaceuticals Inc. Financial Performance

Figure 79: Lucius Pharmaceutical Co. Ltd. Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Ashwagandha Extract Global Market Report 2025 – By Type (Immunity Health, Stress And Anxiety, Weight Loss, General Health ), By Form (Powder, Capsules Or Tablets, Other Forms), By Distribution Channel (Business To Busine...

Cholinergic Drugs Global Market Report 2025 – By Type (Powder, Tablet, Capsule), By Drug Type (Muscarinic Agonists, Nicotinic Agonists, Acetylcholinesterase Inhibitors), By Indication (Alzheimer's Disease, Myasthenia Gra...

Effervescent Tablet Global Market Report 2025 – By Product( Medication, Supplements), By Methods( Dry Methods, Wet Granulation), By Indication( Diuretics, Pain Management, Gastric Disorders, Respiratory Diseases, Other I...

Tea Capsule Global Market Report 2025 – By Product Type (Red Tea Capsules, Oolong Tea Capsules, Black Tea Capsules, Yellow Tea Capsules, Other Product Types), By Distribution Channel (Hypermarkets & Supermarkets, Special...

Methenamine Hippurate Tablets Global Market Report 2025 – By Type (20 Tablets Or Bottle, 6 Tablets Or Bottle), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Application (Uncomplicated ...

Herbal Medicine Global Market Report 2025 – By Product (Capsules And Tablets, Powders, Extracts, Syrups, Other Products), By Category (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Dietary Supplements, Herbal B...

Medicinal Mushroom Global Market Report 2025 – By Type (Shiitake, Reishi, Maitake, Chaga, Cordyceps, Turkey Tail, Other Types), By Form (Fresh, Dried, Other Forms), By Application (Antioxidants, Immune Enhancer, Anti-Can...

Frequently Asked Questions

What is the definition of the Sotorasib Tablets market?

How will the Sotorasib Tablets market drivers and restraints affect the market dynamics? What forces will shape the Sotorasib Tablets industry going forward?

The market major growth driver - Rising Prevalence Of Cancer Fueling The Market Growth Due To Increasing Life Expectancy. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Sotorasib Tablets market?

The sotorasib tablets market size has grown rapidly in recent years. It will grow from $1.71 billion in 2024 to $1.92 billion in 2025 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing prevalence of non-small cell lung cancer, rising awareness of targeted cancer therapies, growing adoption of precision medicine, expansion of oncology treatment centers, and increasing government support for cancer drugs. The sotorasib tablets market size is expected to see rapid growth in the next few years. It will grow to $3.04 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to growing investment in KRAS inhibitor research, expansion of sotorasib manufacturing capacity, increasing collaborations between biotech and pharma companies, rising demand for personalized cancer treatment, and growing use of oral targeted therapies. Major trends in the forecast period include technological advancements in targeted therapy development, developments in KRAS mutation detection methods, investment research and development in oncology drugs, innovation in oral cancer formulations, and advancements in sustainable drug manufacturing practices. For further insights on this market, request a sample here

How is the Sotorasib Tablets market segmented?

The sotorasib tablets market covered in this report is segmented as
1) By Dosage Form: 40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms
2) By Patient Demographics: Adolescents, Adult, Senior Adults
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By Application: Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications
5) By End-User: Hospitals, Oncology Centers, Clinics, Other End-Users For further insights on this market, request a sample here

Which region has the largest share of the Sotorasib Tablets market? What are the other regions covered in the report?

North America was the largest region in the sotorasib tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sotorasib tablets report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Sotorasib Tablets market?

Major companies operating in the sotorasib tablets market are Amgen Inc., Ziska Pharmaceuticals Limited, Everest Pharmaceuticals Inc., Lucius Pharmaceutical Co. Ltd. For further insights on this market, request a sample here.

What are the key trends in the Sotorasib Tablets market?

Major trends in this market include Combination Therapies Show Promise In Extending Progression-Free Survival In Advanced Cancers For further insights on this market, request a sample here.